Phosphorylation of the Hepatitis B Virus Large Envelope Protein

Phosphorylation of the Hepatitis B Virus Large Envelope Protein

We here establish the phosphorylation sites in the human hepatitis B virus (HBV) large envelope protein (L). L is involved in several functionally important interactions in the viral life cycle, including with the HBV cellular receptor, HBV capsid, Hsc70 chaperone, and cellular membranes during fusi...

Full description

Bibliographic Details
Main Authors:	Marie-Laure Fogeron, Lauriane Lecoq, Laura Cole, Roland Montserret, Guillaume David, Adeline Page, Frédéric Delolme, Michael Nassal, Anja Böckmann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Molecular Biosciences
Subjects:	hepatitis B L HBsAg phosphorylation NMR cell-free (CF) protein synthesis mass spectrometry
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2021.821755/full

Similar Items

Phosphorylation and Alternative Translation on Wheat Germ Cell-Free Protein Synthesis of the DHBV Large Envelope Protein
by: Guillaume David, et al.
Published: (2019-12-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Comparative ELISA reagents for detection of hepatitis B surface antigen (HBsAg) Comparação de reativos para o teste de ELISA na evidenciação do antígeno de superfície de hepatite B
by: I. F. Camargo, et al.
Published: (1987-06-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Prevalence of Hepatitis B Surface Antigen in hospital based population in Bijapur, Karnataka
by: Sayed A. Quadri, et al.
Published: (2013-04-01)

Seromarkers of Hepatitis B virus in newborns with HBsAg positive mothers
by: Yousef Yahyapour (PhD), et al.
Published: (2009-05-01)

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
by: Milan J. Sonneveld, et al.
Published: (2023-08-01)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
by: Carla S. Coffin, et al.
Published: (2022-11-01)

Prevalencia de anticuerpos anti-VHC y del antígeno de superficie de la hepatitis B en pacientes tratados con hemodiálisis Prevalence of anti-HCV antibodies and of the hepatitis B surface antigen in patients treated with hemodialysis
by: Zuzet Martínez Córdova, et al.
Published: (2008-03-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan
by: Te-Wei Cheng, et al.
Published: (2023-02-01)

Epidemiological characteristics of acute HBV infection
by: Perić Valerija, et al.
Published: (2019-01-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)

Analysis of S gene characteristic sequences and changes in properties of protein expression in HBV ASCs with low-level HBsAg
by: Yu Yu, et al.
Published: (2022-09-01)

Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Xiao Lin, et al.
Published: (2022-09-01)

Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers
by: Hong Li, et al.
Published: (2022-04-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)

Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)

Hepatitis B Virus (HBV) a Severe Health Problem in Mardan, Khyber Pakhtunkhwa
by: Muhammad Waqar, et al.
Published: (2019-02-01)

Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
by: Abdulbasit R. N. Abuzwaida, et al.
Published: (1987-08-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
by: Xian-ding Wang, et al.
Published: (2021-01-01)

基因工程乙肝疫苗的研制——Ⅲ.MT-5细胞的HBsAg纯化与鉴定
Published: (1990-01-01)

Serological Evaluation of Hepatitis B Virus in Out Patient Department Patients of a Private Hospital in North-West India
by: Smita Sood
Published: (2013-09-01)

Seroprevalence of Hepatitis B virus Infection by Quantitative Chemiluminescent in Tabriz (North West of Iran), 2010-2011
by: Nader Hajizadeh, et al.
Published: (2014-08-01)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
by: Luna Colagrossi, et al.
Published: (2018-07-01)

Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy
by: Muye Xia, et al.
Published: (2025-02-01)

RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies
by: Christine I. Wooddell, et al.
Published: (2021-03-01)

Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study
by: Ying-Ming Chiu, et al.
Published: (2017-11-01)

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
by: Gian Paolo Caviglia, et al.
Published: (2021-11-01)

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
by: Giuseppina Brancaccio, et al.
Published: (2021-04-01)

Functional Cure of Hepatitis B Virus Infection in Individuals With HIV-Coinfection: A Literature Review
by: Anders Boyd, et al.
Published: (2021-07-01)

Seroprevalence of Hepatitis B Surface Antigen among Out Patients Attending a Tertiary Hospital in Kaduna State, Nigeria
by: Uregwu Agnes Edia-Asuke, et al.
Published: (2016-12-01)

Rupestonic Acid Derivative YZH-106 Promotes Lysosomal Degradation of HBV L- and M-HBsAg via Direct Interaction with PreS2 Domain
by: Lanlan Liu, et al.
Published: (2024-07-01)

A Comparative study on the prevalence of HCC seromarkers among tribal and coastal population
by: Joseph Selvin, et al.
Published: (2010-03-01)